ARCHIVES

Satraplatin Improved PFS In Refractory Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 26 No. 7 | July 25, 2003

Download PDF Visit The Full Archive

Related Articles

BMI May Be Prognostic Tool For Types Of Breast Cancer

March 28, 2008

Conversation with The Cancer Letter: Daniel Hayes Leads Tour of Caris Website

August 8, 2014

ODAC Recommends Iressa Approval As Third-Line Lung Cancer Treatment

September 27, 2002

USC wins $3.5 million NCI grant.

April 23, 2004

NCI-Approved Clinical Trials

July 28, 2006

Organ Systems Program Progress, Momentum Threatened During transition, Karr Contends

December 9, 1988